DOI:
10.1055/s-00050348
Indian Journal of Medical and Paediatric Oncology
LinksClose Window
References
Kaufman HL, Russell JS, Hamid O. et al.
Updated efficacy of avelumab in patients with previously treated metastatic Merkel cell carcinoma after ≥1 year of follow-up: JAVELIN Merkel 200, a phase 2 clinical trial.
J Immunother Cancer 2018;
6 (01) 7
DOI: 10.1186/s40425-017-0310-x.
We do not assume any responsibility for the contents of the web pages of other providers.